NewAmsterdam Pharma Corporation (@newamspharma) 's Twitter Profile
NewAmsterdam Pharma Corporation

@newamspharma

NewAmsterdam Pharma Corporation is a late-stage clinical biopharma company developing therapies for cardiometabolic diseases. Intended for US audiences only.

ID: 1424851352463753221

linkhttps://www.newamsterdampharma.com/ calendar_today09-08-2021 21:54:12

376 Tweet

873 Takipçi

111 Takip Edilen

NewAmsterdam Pharma Corporation (@newamspharma) 's Twitter Profile Photo
NewAmsterdam Pharma Corporation
@newamspharma

a month ago

A new Nature Reviews Cardiology publication reinforces the growing consensus that with LDL-C, “lower is better, and earlier is better,” suggesting that cumulative exposure to LDL can be used as a biomarker to estimate cardiovascular risk. Explore the evidence and practical applications:

A new <a href="/NatRevCardiol/">Nature Reviews Cardiology</a> publication reinforces the growing consensus that with LDL-C, “lower is better, and earlier is better,” suggesting that cumulative exposure to LDL can be used as a biomarker to estimate cardiovascular risk. Explore the evidence and practical applications: